The possible role of gastric acid against non-steroidal anti-inflammatory drugs-induced gastric microcirculatory disturbance in rats

Japanese Pharmacology and Therapeutics

Volumn 32, Issue 7, 2004, Pages 429-434

  Funatsu, Toshiyuki ^a   Chono, Koji ^a   Hirata, Takuya ^a   Keto, Yoshihiro ^a   Kimoto, Aishi ^a   Sasamata, Masao ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

Gastric acid; Gastric mucosal blood flow; Non steroidal anti inflammatory drugs

Indexed keywords

DICLOFENAC; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG INDUCED DISEASE; IMAGING SYSTEM; LASER DOPPLER FLOWMETRY; NONHUMAN; PROSTAGLANDIN RELEASE; RAT; STOMACH ACID; STOMACH ACID SECRETION; STOMACH BLOOD FLOW; STOMACH DISEASE; STOMACH MUCOSA; VASCULAR RESISTANCE;

EID: 4143088048     PISSN: 03863603     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-18.
2. Singh G, Ramey DR, Morfeld D, Shi H, Hatoum HT, Fries JF. Gastrointestinal tract complications of nonsteroidal anti-inflammatory drug treatment in rheumatoid arthritis. A prospective observational cohort study. Arch Intern Med 1996; 156: 1530-6.
3. Kawano S, Tsuji S, Sato N, Kamada T. NSAIDS and the microcirculation of the stomach. Gastroenterol Clin North Am 1996; 25: 299-315.
4. Ligumsky M, Golanska EM, Hansen DG, Kauffman GL Jr. Aspirin can inhibit gastric mucosal cyclo-oxygenase without causing lesions in rat. Gastroenterology 1983; 84: 756-61.
5. Frezza M, Gorji N, Melato M. The histopathology of non-steroidal anti-inflammatory drug induced gastroduodenal damage: correlation with Helicobacter pylori, ulcers, and haemorrhagic events. J Clin Pathol 2001; 54: 521-5.
6. Miyata K, Kamato T, Nishida A, Honda K. Studies on the mechanism for the gastric mucosal protection by famotidine in rats. Jpn J Pharmacol 1991; 55: 211-22.
7. 2-receptor antagonist with local gastroprotective activity. Eur J Gastroenterol Hepatol 1991; 3: 941-7.
8. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K. Cyclo-oxygenase isozymes in mucosal ulcergenic and functional responses following barrier disruption in rat stomachs. Br J Pharmacol 1997; 122: 447-54.
9. Jakobsson A, Nilsson GE. Prediction of sampling depth and photon pathlength in laser Doppler flowmetry. Med Biol Eng Comp 1993; 31: 301-7.
10. Shorrock CJ, Rees WD. Mechanisms of gastric damage by non-steroidal anti-inflammatory drugs. Scand J Rheumatol 1989; 78: 5-11.
11. Keto Y, Funatsu T, Hirata T, Toyama T, Sudoh K, Sasamata M. Inhibitory effects of famotidine on NSAIDs and bisphosphonate-induced gastric mucosal lesions in rats-Comparison with proton pump inhibitor and gastric mucosal protective agents. Jpn Pharmacol Ther 2003; 31: 485-93.
12. Phillipson M, Henriksnas J, Holstad M, Sandler S, Holm L. Inducible nitric oxide synthase is involved in acid-induced gastric hyperemia in rats and mice. Am J Physiol 2003; 285: G154-62.
13. Kato S, Takeuchi K, Okabe S. Mechanism by which histamine increases gastric mucosal blood flow in the rat. Role of luminal H +. Dig Dis Sci 1993; 38: 1224-32.
14. Katori M, Nishiyama K, Ueno A, Suzuki Y. Possible role of endogenous prostaglandins against ethanol injury in rat stomach. J Clin Gastroenterol 1990; 12: S25-31.
15. Kawano S, Tsuji S. Role of mucosal blood flow: a conceptional review in gastric mucosal injury and protection. J Gastroenterol Hepatol 2000; 15: D1-6.
16. 3-secretion in rats: relation to capsaicin-sensitive afferent neurons. Dig Dis Sci 2002; 47: 2696-703.
17. Someya A, Horie S, Yamamoto H, Murayama T. Modifications of capsaicin-sensitive neurons in isolated guinea pig ileum by [6]-gingerol and lafutidine. J Pharmacol Sci 2003; 92: 359-66.
18. Nishihara K, Nozawa Y, Nakano M, Ajioka H, Matsuura N. Sensitizing effects of lafutidine on CGRP-containing afferent nerves in the rat stomach. Br J Pharmacol 2002; 135: 1487-94.